SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899243-02-002261
Filing Date
2002-08-13
Accepted
2002-08-13 16:26:22
Documents
4
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING JUNE 30, 2002 d10q.txt 10-Q 146797
3 2002 KEY EXECUTIVE PERFORMANCE STOCK OPTION PLAN dex101.txt EX-10.1 33789
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex991.txt EX-99.1 1056
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex992.txt EX-99.2 1068
  Complete submission text file 0000899243-02-002261.txt   184669
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 02730048
SIC: 8093 Services-Specialty Outpatient Facilities, NEC